Elevation Oncology Inc ELEV:NASDAQ

RT Quote | USD
Last | 05/14/24 EDT
3.56quote price arrow up+0.02 (+0.56%)
Volume
375,965
52 week range
0.36 - 5.89
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.54
  • 52 Week High5.89
  • 52 Week High Date05/26/23
  • 52 Week Low0.36
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap194.512M
  • Shares Out54.64M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change562.94

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.54
  • 52 Week High5.89
  • 52 Week High Date05/26/23
  • 52 Week Low0.36
  • 52 Week Low Date11/13/23
  • Market Cap194.512M
  • Shares Out54.64M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change562.94

RATIOS/PROFITABILITY

  • EPS (TTM)-1.03
  • P/E (TTM)-3.46
  • Fwd P/E (NTM)-4.16
  • EBITDA (TTM)-38.53M
  • ROE (TTM)-71.82%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)40.64%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Elevation Oncology Inc

 

Profile

MORE
Elevation Oncology, Inc. is an oncology company. The Company is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. EO-3021 consists of a fully human immunoglobulin G1...
Steven Elms
Chairman of the Board
Joseph Ferra Jr.
President, Chief Executive Officer, Director
Tammy Furlong CPA
Chief Financial Officer
Address
101 Federal Street, Suite 1900
Boston, MA
02110
United States

Top Peers

SYMBOLLASTCHG%CHG
DRTS
Alpha Tau Medical Ltd
2.63-0.02-0.60%
GLSI
Greenwich Lifesciences Inc
13.64+0.58+4.44%
XFOR
X4 Pharmaceuticals Inc
0.9854+0.0088+0.9011%
ATOS
Atossa Therapeutics Inc
1.54+0.08+5.48%
GALT
Galectin Therapeutics Inc
2.84-0.24-7.79%